-
Sidley Updates
Medicare Part D’s New Cost-Smoothing Program: Key Insights and Impacts
September 17, 2024
Healthcare Update
-
Watch
Navigate Investment and Drug Development Under the IRA
January 2024
Global IR @JPMorgan Healthcare Conference
-
Watch
IRA Considerations for Life Sciences Investors
October 19, 2023
Biotechnology Innovation Organization
-
Sidley Updates
Inflation Reduction Act: CMS Releases New “Medicare Drug Price Negotiation Program” Guidance as Industry Lawsuits Mount
July 14, 2023
Global Life Sciences Update
-
Blogs
Impact Of Inflation Reduction Act On Drug Development For U.S. Market
May 23, 2023
GoodLifeSci
-
Sidley Updates
HHS Faces IRA Implementation Risk Without Notice and Comment
April 3, 2023
Global Life Sciences Update
-
Webinar
Navigating The IRA: What Biopharmas Need To Know
Thursday, March 30, 2023
Presented by BioCentury and Putnam
-
Sidley Updates
Inflation Reduction Act: CMS Solicits Comments on Price Negotiation Program Guidance, Makes Part B Coinsurance Announcements
March 20, 2023
Global Life Sciences Update
-
Sidley Updates
U.S. Inflation Reduction Act Implementation: Public Opportunities to Comment on New Medicare Inflation Rebates Program
February 17, 2023
Global Life Sciences Update
-
Sidley Updates
Inflation Reduction Act Implementation: Serious Hurdles to Accurately Calculating Medicare Part B Inflation Rebates
February 14, 2023
Global Life Sciences Update
-
Sidley Updates
Inflation Reduction Act Implementation: Public Input Opportunities Related to U.S. Medicare Drug Price Negotiation Program
February 3, 2023
Global Life Sciences Update
-
Publications
Increasingly, Life Sciences and Healthcare Providers Proactively Consider Offensive Challenges to U.S. Government Agencies
January 2023
Trendspotting 2023: On the Pulse of Global Life Sciences
-
Sidley Updates
Unprecedented Changes to Medicare Programs Leave Many Questions Unanswered for Pharmaceutical Manufacturers
August 29, 2022
Global Life Sciences Update
